CME Group Company Profile (NASDAQ:CME)

CME Group trades on the NASDAQ under the ticker symbol "CME."

CME Group declared a quarterly dividend on Tuesday, May 23rd. Stockholders of record on Friday, June 9th will be paid a dividend of $0.66 per share on Monday, June 26th. This represents a $2.64 annualized dividend and a dividend yield of 2.13%. The ex-dividend date of this dividend is Wednesday, June 7th. View CME Group's Dividend History.

CME Group Inc (NASDAQ:CME) released its quarterly earnings data on Thursday, April, 27th. The company reported $1.22 earnings per share (EPS) for the quarter, beating the Thomson Reuters' consensus estimate of $1.20 by $0.02. The business had revenue of $929 million for the quarter, compared to the consensus estimate of $932.06 million. CME Group had a return on equity of 7.84% and a net margin of 43.02%. The firm's revenue for the quarter was down .5% compared to the same quarter last year. During the same period in the prior year, the business earned $1.15 earnings per share. View CME Group's Earnings History.

CME Group is scheduled to release their next quarterly earnings announcement on Tuesday, August, 1st 2017. View Earnings Estimates for CME Group.

6 brokerages have issued 12-month price objectives for CME Group's stock. Their forecasts range from $99.00 to $135.00. On average, they expect CME Group's share price to reach $119.00 in the next year. View Analyst Ratings for CME Group.

Here are some recent quotes from research analysts about CME Group stock:

• 1. According to Zacks Investment Research, "Shares of CME Group have outperformed the Zacks categorized Securities Exchanges industry, in the last one year. CME Group remains well positioned for growth on the back of its strong market position with diverse derivative product lines. Efforts to expand and cross sell its core exchange-traded business through new product initiatives and global reach also support growth. Reaffirming its commitment to boost shareholders’ value, CME Group announced its annual variable dividend in Dec 2016. However, mounting expenses remain a concern for CME Group. The company projects higher expense in 2017.Also, exposure to interest rate volatility, limited credit availability in the current unstable capital and credit markets, can hamper liquidity." (3/20/2017)
• 2. J P Morgan Chase & Co analysts commented, "CME reported GAAP EPS of $0.95 and Adjusted EPS of $1.14. Revenue was a bit lower than expected on product RPC even though the mix generally improved for the quarter. Expenses were also lower, particularly comp. CME has a lot going on in product development and will invest more to bring a number of products to market. While we feel such investments are critical, we also feel that investors will only pay for them after-the-fact, rather than before. We continue to think of CME as a true income-growth investment idea and thus maintain the Overweight rating." (7/29/2016)

CME Group saw a drop in short interest in May. As of May 15th, there was short interest totalling 5,281,233 shares, a drop of 19.3% from the April 28th total of 6,542,645 shares. Based on an average trading volume of 1,451,335 shares, the short-interest ratio is presently 3.6 days. Approximately 1.6% of the shares of the stock are short sold.

Some companies that are related to CME Group include Bank of Nova Scotia (BNS), UBS Group AG (UBS), Banco Bilbao Vizcaya Argentaria SA (BBVA), Lloyds Banking Group PLC (LLOY), Prudential plc (PRU), Barclays PLC (BCS), Barclays PLC (BARC), AFLAC Incorporated (AFL), Royal Bank of Scotland Group plc (RBS), Progressive Corp (PGR), Equity Residential (EQR), Standard Chartered PLC (STAN), TD Ameritrade Holding Corp. (AMTD), Aviva plc (AV), Shinhan Financial Group Co. (SHG), Essex Property Trust (ESS), Legal & General Group Plc (LGEN) and London Stock Exchange Group Plc (LSE).

CME Group's management team includes the folowing people:

• Terrence A. Duffy, Executive Chairman of the Board, Chief Executive Officer
• Bryan T. Durkin, President
• Charles Peter Carey, Vice Chairman of the Board
• John W. Pietrowhicz CPA, Chief Financial Officer
• Sunil Cutinho, President - CME Clearing
• Kimberly S. Taylor, President - Clearing and Post-Trade Services
• Hilda Harris Piell, Chief Human Resource Officer, Senior Managing Director
• Jack J. Tobin, Chief Accounting Officer
• Kevin Kometer, Chief Information Officer, Senior Managing Director
• Kathleen M. Cronin, Senior Managing Director, General Counsel, Corporate Secretary

CME Group's stock is owned by a variety of of retail and institutional investors. Top institutional investors include BlackRock Inc. (8.02%), Vanguard Group Inc. (6.54%), State Street Corp (5.21%), Edgewood Management LLC (2.13%), FMR LLC (1.79%) and Bank of New York Mellon Corp (1.68%). Company insiders that own CME Group stock include Bryan T Durkin, Dennis Suskind, Derek Sammann, Hilda Harris Piell, James E Oliff, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Kimberly S Taylor, Martin J Gepsman, Phupinder Gill, Robert Zagotta, Ronald A Pankau, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Institutional Ownership Trends for CME Group.

CME Group's stock was sold by a variety of institutional investors in the last quarter, including OppenheimerFunds Inc., FMR LLC, Thornburg Investment Management Inc., Ameriprise Financial Inc., Credit Agricole S A, Waddell & Reed Financial Inc., Epoch Investment Partners Inc. and Dimensional Fund Advisors LP. Company insiders that have sold CME Group stock in the last year include Bryan T Durkin, Dennis Suskind, Derek Sammann, Hilda Harris Piell, James E Oliff, Jeffrey M Bernacchi, John W Pietrowicz, Julie Holzrichter, Julie Winkler, Kathleen M Cronin, Kevin Kometer, Kimberly S Taylor, Martin J Gepsman, Phupinder Gill, Ronald A Pankau, Sunil Cutinho, Terrence A Duffy and Timothy S Bitsberger. View Insider Buying and Selling for CME Group.

CME Group's stock was acquired by a variety of institutional investors in the last quarter, including BlackRock Inc., Edgewood Management LLC, APG Asset Management N.V., Vanguard Group Inc., Wells Fargo & Company MN, Morgan Stanley, Sumitomo Mitsui Financial Group Inc. and UBS Group AG. View Insider Buying and Selling for CME Group.

Shares of CME Group can be purchased through any online brokerage account. Popular online brokerages include Vanguard Brokerage Services, TD Ameritrade, E*TRADE, Scottrade, Fidelity and Charles Schwab.

One share of CME Group stock can currently be purchased for approximately $124.12.